SIMI - Società Italiana di Medicina Interna

CRIS - 18 dicembre 2014

Pubblicazioni studio Reposi

Elenco pubblicazioni

Pubblicazioni studio REPOSI.docx

1. In-hospital death and adverse clinical events in elderly patients according to disease clustering- the REPOSI study Rejuvenation Res 2010.pdf

2. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards Eur J Int Med 2010.pdf

3. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly Eur J Int Med 2011.pdf

4. Polypharmacy%2C length of hospital stay%2C and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study Eur J Clin Pharmacol 2011.pdf

5. In-hospital death according to dementia diagnosis in acutely ill elderly patients- the REPOSI study Int J Geriat Phyc 2011.pdf

6. Association between clusters of diseases and polypharmacy in hospitalized elderly patients- results from the REPOSI study Eur J Int Med 2011.pdf

7. Prevalence%2C characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards Eur J Int Med 2018.pdf

8. Risk factors for hospital readmission of elderly patients Eur J Int Med 2013.pdf

9. Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 Gerontology 2013.pdf

10. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized e%C3%B2derly Drugs Aging 2013.pdf

11. Adverse clinical events and mortality during hospitalization and 3 months after discharge in cognitively impaired elderly patients J Gerontology a Biol Sci Med Sci 2013.pdf

12. Prophylaxis of venous thromboembolism in elderly patients with multimorbidity Int Emerg Med 2013.pdf

13. Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation Eur J Int Med 2013.pdf

14. Prescription drug use among older adults in Italy JAMDA 2014.pdf

15. Gender-differences in disease distribution and outcome in hospitalized elderly- data from the REPOSI study Eur J int Med 2014.pdf

16. Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients Int Emerg Med 2014.pdf

17. Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients- results from the REPOSI Study J Clin Pharm Ther 2014.pdf

18. Multimorbidity and polypharmacy in the elderly- lessons from REPOSI Intern Emerg Med 2014.pdf

19. Gout%2C allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly Eur J Int Med 2014.pdf

20. Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly- results from the REPOSI registry Eur J Clin Pharmacol 2014.pdf

21. Prophylaxis of venous thromboembolism in elderly patients with multi-morbidity- the REPOSI data Int Emerg Med 2015.pdf

22. The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy Int Emerg Med 2015.pdf

23. Brain and kidney victims of atrial micorembolism in elderly Eur J Inter Med 2015.pdf

24. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia Eur Journ Intern Medicine 2015.pdf

25. Gender difference in drug use in hospitalized elderly patients Eur J Int Med 2015.pdf

26. Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards Eur J Int Med 2015.pdf

27. Appropriateness of antithrombotic prophylaxis in the oldest old with non-valvular atrial fibrillation- ARAPACIS and REPOSI Eur J Int Med 2015.pdf

28. Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People Drugs Aging 2016.pdf

29. Predictors of clinical events occurring during hospital stay among elderly patients admitted to medical wards in Italy Eur J Int Med 2016.pdf

30. Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients- Results from the REPOSI Study Drugs Aging 2016.pdf

31. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation- insights from the REPOSI study Clin Res Cardiol 2016.pdf

32. Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients- Results from the REPOSI study Eur J Int Med 2017.pdf

33. Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients Arch Geront Geriat 2017.pdf

34. Defining Aging Phenotypes and Related Outcomes- Clues to Recognize Frailty in Hospitalized Older Patients J Gerontol A Biol Sci Med Sci 2017.pdf

35. Prevalence and determinants of th euse of lipid lowering agents in a popupation of older hospitalized patients Drugs Aging 2017.pdf

36. Prevalence of older in-patients at risk of clopidogrel resistance according to the STIB score. Results from REPOSI registry Eur J Int Med 2017.pdf

37. Does rhythm or rate control strategy influence anticoagulant treatment in older patients with atrial fibrillation Eur J Int Med 2017.pdf

38. Antipsychotic prescription and mortality in hospitalized older persons Psychogeriatrics 2017.pdf

39. Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people Br J Clin Pharmacol 2017.pdf

40. Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 Pharmacoepidemiol Drug Saf 2017.pdf

41. Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients- Results from the REPOSI study Arch Geront Geriat 2018.pdf

42. Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation- A Report from the REPOSI Study Drugs Aging 2018.pdf

43. Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients Eur J int Med 2018.pdf

44. Disability%2C and not diabetes%2C is a strong predictor of mortality in oldest old patients hospitalized with pneumonia Eur J Int Med 2018.pdf

45. Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients Ont Psychogeriatrics 2012.pdf

46. Implementation of the Frailty Index in hospitalized older patients- Results from the REPOSI register Eur J Int Med 2018.pdf

47. Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients Eur J Int Med 2018.pdf

48. Polypharmacy in older people- lessons from 10 years of experience with the REPOSI register Int Emerg Med 2018.pdf

49. Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy- The REPOSI Study Med Princ Pract 2019.pdf

50. Sex-Differences in the Pattern of Comorbidities%2C Functional Independence%2C and Mortality in Elderly Inpatients- Evidence from the RePoSI Register J Clin Med 2019.pdf

51. Mortality rate and risk factors for gastrointestinal bleeding in elderly patients Eur J Int Med 2019.pdf

52. Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patient Eur J Int Med 2019.pdf

53. Inappropriate prescription of benzodiazepines in acutely hospitalized older patients European Neuropharmacol 2019.pdf

54. Hospital Care of Older Patients With COPD- Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids JAMDA 2019.pdf

55. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients Eur J Int Med 2019.pdf

56. Patterns of infections in older patients acutely admitted to medical wards- data from the REPOSI register Int Emerg Med 2019.pdf

57. Antibiotic use and associated factors in a large sample of hospitalised older people J Glob Antimicrob Resistance 2019.pdf

58. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people Eur J Clin Pharmacol 2020.pdf

59. Comorbidity does not mean clinical complexity- evidence from the RePoSI register Int Emerg Med 2020.pdf

60. Potentially inappropriate medications drug-drug interaction and anticholinergic burden in elderly hospitalized patients Drugs Aging 2020.pdf

61. Pain and Frailty in Hospitalized Older Adults Pain Ther 2020.pdf

62. Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge JAMDA 2021.pdf

63. What changed in the Italian internal medicine and geriatric wards during the lockdown Eur J Int Med 2021.pdf

64. Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) Endocrine 2021.pdf

65. The multifaceted spectrum of liver cirrhosis in older hospitalised patients- analysis of the REPOSI registry Age and Ageing 2021.pdf

66. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards- data from the RePoSI Registry Int Emerg Med 2020.pdf

67. Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects Aging Clin Exp Res 2021.pdf

68. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients Clin Interv Aging 2021.pdf

69. Hyperglycemia at admission%2C comorbidities%2C and in-hospital mortality in elderly patients hospitalized in internal medicine wards- data from the RePoSI Registry Acta Diab 2021.pdf

70. Kidney Disease Management in the Hospital Setting- A Focus on Inappropriate Drug Prescriptions in Older Patients Front Pharmacol 2021.pdf

71. Renal Function Cardiovascular Disease appropriateness of drug presciptio Drug and aging 2021.pdf

72. Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards- Data from the RePoSi Registry Heakthcare 2022.pdf

73. Beta blocer us ein older hospitalized patients affected by HF and COPD REPOSIFront Cardiovasc Med 2022.pdf

74. Diabetes comorbidome REPOSI Healthcare 2022.pdf

75. Relation between drug therapy-based comorbidity index%2C Charlson comorbidity index%2C polypharmacy and mortality REPOSI Archives of Gerontology and Geriatrics 2022.pdf

1090

NEWS RECENTI

APERTURA ISCRIZIONI CORSO PRE CONGRESSUALE E CONGRESSO SIMI SEZIONE SICILIA MESSINA 19 nov 2024

APERTURA ISCRIZIONI CONGRESSO SIMI SEZIONE CALABRIA, 29 NOVEMBRE 2024 19 nov 2024

APERTURA ISCRIZIONI FOCUS IN MEDICINA INTERNA: LA MALNUTRIZIONE, 28 NOVEMBRE 2024 MILANO 27 ott 2024

Medicina interna 3.0. Si riparte dalla rinnovata alleanza SIMI-FADOI 23 ott 2024

RASSEGNA STAMPA 125° CONGRESSO DELLA SIMI 2024 23 ott 2024